Poewe W - Search Results

1

[Long-term results of continuous subcutaneous apomorphine pump therapy in patients with advanced Parkinson disease].

Kreczy-Kleedorfer B, Wagner M, Bösch S, Poewe W. Kreczy-Kleedorfer B, et al. Among authors: poewe w. Nervenarzt. 1993 Apr;64(4):221-5. Nervenarzt. 1993. PMID: 8506009 German. No abstract available.

2

Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease.

Wenning GK, Bösch S, Luginger E, Wagner M, Poewe W. Wenning GK, et al. Among authors: poewe w. Adv Neurol. 1999;80:545-8. Adv Neurol. 1999. PMID: 10410769 Review. No abstract available.

3

Continuous subcutaneous apomorphine infusions for fluctuating Parkinson's disease. Long-term follow-up in 18 patients.

Poewe W, Kleedorfer B, Wagner M, Bösch S, Schelosky L. Poewe W, et al. Adv Neurol. 1993;60:656-9. Adv Neurol. 1993. PMID: 8420206 No abstract available.

4

Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's disease.

Luginger E, Wenning GK, Bösch S, Poewe W. Luginger E, et al. Among authors: poewe w. Mov Disord. 2000 Sep;15(5):873-8. doi: 10.1002/1531-8257(200009)15:5<873::aid-mds1017>3.0.co;2-i. Mov Disord. 2000. PMID: 11009193 Clinical Trial.

5

[Therapeutic experiences with a slow-release preparation of L-dopa (Madopar "HBS") in patients with advanced Parkinson disease].

Poewe W, Kleedorfer B, Gerstenbrand F. Poewe W, et al. Nervenarzt. 1989 May;60(5):294-8. Nervenarzt. 1989. PMID: 2739822 German. No abstract available.

6

Side-effects of subcutaneous apomorphine in Parkinson's disease.

Poewe W, Kleedorfer B, Wagner M, Benke T, Gasser T, Oertel W. Poewe W, et al. Lancet. 1989 May 13;1(8646):1084-5. doi: 10.1016/s0140-6736(89)92487-2. Lancet. 1989. PMID: 2566037 No abstract available.

7

Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients.

Poewe W, Schelosky L, Kleedorfer B, Heinen F, Wagner M, Deuschl G. Poewe W, et al. J Neurol. 1992 Jan;239(1):21-5. doi: 10.1007/BF00839206. J Neurol. 1992. PMID: 1541964 Clinical Trial.

8

[Atypical Parkinson syndrome].

Wenning GK, Pramstaller PP, Ransmayr G, Poewe W. Wenning GK, et al. Among authors: poewe w. Nervenarzt. 1997 Feb;68(2):102-15. doi: 10.1007/s001150050104. Nervenarzt. 1997. PMID: 9173309 Review. German.

9

Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study.

Wenning GK, Scherfler C, Granata R, Bösch S, Verny M, Chaudhuri KR, Jellinger K, Poewe W, Litvan I. Wenning GK, et al. Among authors: poewe w. J Neurol Neurosurg Psychiatry. 1999 Nov;67(5):620-3. doi: 10.1136/jnnp.67.5.620. J Neurol Neurosurg Psychiatry. 1999. PMID: 10519868 Free PMC article.

10

[Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement].

Trenkwalder C, Boesch S, Ceballos-Baumann A, Dressler D, Eggert K, Gasser T, Honig H, Müller T, Reichmann H, Sieb JP, Storch A, Odin P, Poewe W. Trenkwalder C, et al. Among authors: poewe w. Nervenarzt. 2008 Apr;79(4):475-9. doi: 10.1007/s00115-007-2391-0. Nervenarzt. 2008. PMID: 18210043 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

873 results

Search Page